A Study to Determine the Safety and Efficacy of Rilpivirine in Treatment-naive Indian Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Clinical trial NCT03563742 · TERMINATED
Trial details
- NCT number
- NCT03563742
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-24
- Primary completion
- 2021-06-28
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.